BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

301 related articles for article (PubMed ID: 28536400)

  • 1. HGF/c-MET Axis in Tumor Microenvironment and Metastasis Formation.
    Spina A; De Pasquale V; Cerulo G; Cocchiaro P; Della Morte R; Avallone L; Pavone LM
    Biomedicines; 2015 Jan; 3(1):71-88. PubMed ID: 28536400
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatocyte Growth Factor, a Key Tumor-Promoting Factor in the Tumor Microenvironment.
    Owusu BY; Galemmo R; Janetka J; Klampfer L
    Cancers (Basel); 2017 Apr; 9(4):. PubMed ID: 28420162
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Extracellular Matrix Influencing HGF/c-MET Signaling Pathway: Impact on Cancer Progression.
    Noriega-Guerra H; Freitas VM
    Int J Mol Sci; 2018 Oct; 19(11):. PubMed ID: 30352967
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of HGF/MET axis in resistance of lung cancer to contemporary management.
    Raghav KP; Gonzalez-Angulo AM; Blumenschein GR
    Transl Lung Cancer Res; 2012 Sep; 1(3):179-93. PubMed ID: 25806180
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Crosstalk Mechanisms Between HGF/c-Met Axis and ncRNAs in Malignancy.
    Liu X; Sun R; Chen J; Liu L; Cui X; Shen S; Cui G; Ren Z; Yu Z
    Front Cell Dev Biol; 2020; 8():23. PubMed ID: 32083078
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatocyte growth factor and Met in tumor biology and therapeutic approach with NK4.
    Matsumoto K; Nakamura T; Sakai K; Nakamura T
    Proteomics; 2008 Aug; 8(16):3360-70. PubMed ID: 18646008
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HGF/Met Signaling in Head and Neck Cancer: Impact on the Tumor Microenvironment.
    Hartmann S; Bhola NE; Grandis JR
    Clin Cancer Res; 2016 Aug; 22(16):4005-13. PubMed ID: 27370607
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatocyte growth factor in physiology and infectious diseases.
    Imamura R; Matsumoto K
    Cytokine; 2017 Oct; 98():97-106. PubMed ID: 28094206
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular co-expression of the c-Met oncogene and hepatocyte growth factor in primary colon cancer predicts tumor stage and clinical outcome.
    Kammula US; Kuntz EJ; Francone TD; Zeng Z; Shia J; Landmann RG; Paty PB; Weiser MR
    Cancer Lett; 2007 Apr; 248(2):219-28. PubMed ID: 16945480
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MET/HGF Co-Targeting in Pancreatic Cancer: A Tool to Provide Insight into the Tumor/Stroma Crosstalk.
    Modica C; Tortarolo D; Comoglio PM; Basilico C; Vigna E
    Int J Mol Sci; 2018 Dec; 19(12):. PubMed ID: 30544501
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The biological role of HGF-MET axis in tumor growth and development of metastasis.
    Lesko E; Majka M
    Front Biosci; 2008 Jan; 13():1271-80. PubMed ID: 17981628
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting the Hepatocyte Growth Factor and c-Met Signaling Axis in Bone Metastases.
    Whang YM; Jung SP; Kim MK; Chang IH; Park SI
    Int J Mol Sci; 2019 Jan; 20(2):. PubMed ID: 30658428
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Insulinlike growth factor-I-mediated migration and invasion of human colon carcinoma cells requires activation of c-Met and urokinase plasminogen activator receptor.
    Bauer TW; Fan F; Liu W; Johnson M; Parikh NU; Parry GC; Callahan J; Mazar AP; Gallick GE; Ellis LM
    Ann Surg; 2005 May; 241(5):748-56; discussion 756-8. PubMed ID: 15849510
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HGF-mediated crosstalk between cancer-associated fibroblasts and MET-unamplified gastric cancer cells activates coordinated tumorigenesis and metastasis.
    Ding X; Ji J; Jiang J; Cai Q; Wang C; Shi M; Yu Y; Zhu Z; Zhang J
    Cell Death Dis; 2018 Aug; 9(9):867. PubMed ID: 30158543
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic Ablation of the MET Oncogene Defines a Crucial Role of the HGF/MET Axis in Cell-Autonomous Functions Driving Tumor Dissemination.
    Modica C; Cortese M; Bersani F; Lombardi AM; Napoli F; Righi L; Taulli R; Basilico C; Vigna E
    Cancers (Basel); 2023 May; 15(10):. PubMed ID: 37345079
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transforming growth factor-beta signaling-deficient fibroblasts enhance hepatocyte growth factor signaling in mammary carcinoma cells to promote scattering and invasion.
    Cheng N; Chytil A; Shyr Y; Joly A; Moses HL
    Mol Cancer Res; 2008 Oct; 6(10):1521-33. PubMed ID: 18922968
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Role of HGF/MET Signaling in Metastatic Uveal Melanoma.
    Tanaka R; Terai M; Londin E; Sato T
    Cancers (Basel); 2021 Oct; 13(21):. PubMed ID: 34771620
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HGF/MET Axis Induces Tumor Secretion of Tenascin-C and Promotes Stromal Rewiring in Pancreatic Cancer.
    Modica C; Olivero M; Zuppini F; Milan M; Basilico C; Vigna E
    Cancers (Basel); 2021 Jul; 13(14):. PubMed ID: 34298732
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quercetin inhibits HGF/c-Met signaling and HGF-stimulated melanoma cell migration and invasion.
    Cao HH; Cheng CY; Su T; Fu XQ; Guo H; Li T; Tse AK; Kwan HY; Yu H; Yu ZL
    Mol Cancer; 2015 May; 14():103. PubMed ID: 25971889
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of pro-HGF activation by SRI31215, a novel approach to block oncogenic HGF/MET signaling.
    Owusu BY; Bansal N; Venukadasula PK; Ross LJ; Messick TE; Goel S; Galemmo RA; Klampfer L
    Oncotarget; 2016 May; 7(20):29492-506. PubMed ID: 27121052
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.